Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial

Journal of Trauma and Acute Care Surgery

Volumn 85, Issue 5, 2018, Pages 851-857

  Khan, Muhammad ^a   Jehan, Faisal ^a   Bulger, Eileen M ^b   O'Keeffe, Terence ^a   Holcomb, John B ^c   Wade, Charles E ^c   Schreiber, Martin A ^d   Joseph, Bellal ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hyperfibrinolysis; resuscitation; tranexamic acid; trauma

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GLASGOW COMA SCALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERFIBRINOLYSIS; INJURY SCALE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; SURVIVAL RATE; THROMBOELASTOGRAPHY; BLEEDING; COMPLICATION; DRUG EFFECT; FIBRINOLYSIS; HEMOSTASIS; INJURY; MIDDLE AGED; PATHOPHYSIOLOGY; PLASMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); YOUNG ADULT;

ADULT; ANTIFIBRINOLYTIC AGENTS; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HEMOSTASIS; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PLASMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TRANEXAMIC ACID; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 85055595985     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000002022     Document Type: Conference Paper

References (28)

1. Rhee P Joseph B Pandit V Aziz H Vercruysse G Kulvatunyou N Friese RS. Increasing trauma deaths in the United States. Ann Surg. 2014; 260 (1): 13-21.
2. Acosta JA Yang JC Winchell RJ Simons RK Fortlage DA Hollingsworth-Fridlund P Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998; 186 (5): 528-533.
3. Holcomb JB Tilley BC Baraniuk S Fox EE Wade CE Podbielski JM del Junco DJ Brasel KJ Bulger EM Callcut RA. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial. JAMA. 2015; 313 (5): 471-482.
4. Holcomb JB Jenkins D Rhee P Johannigman J Mahoney P Mehta S Cox ED Gehrke MJ Beilman GJ Schreiber M. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma Acute Care Surg. 2007; 62 (2): 307-310.
5. Kashuk JL Moore EE Sawyer M Wohlauer M Pezold M Barnett C Biffl WL Burlew CC Johnson JL Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010; 252 (3): 434-442.
6. Moore HB Moore EE Liras IN Gonzalez E Harvin JA Holcomb JB Sauaia A Cotton BA. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: A multicenter evaluation of 2,540 severely injured patients. J Am Coll Surg. 2016; 222 (4): 347-355.
7. Cotton BA Harvin JA Kostousouv V Minei KM Radwan ZA Schöchl H Wade CE Holcomb JB Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012; 73 (2): 365-370.
8. Dunn CJ Goa KL. Tranexamic acid. Drugs. 1999; 57 (6): 1005-1032.
9. Huang F Wu D Ma G Yin Z Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: A meta-Analysis. J Surg Res. 2014; 186 (1): 318-327.
10. Shakur H Roberts I Fawole B Chaudhri R El-Sheikh M Akintan A Qureshi Z Kidanto H Vwalika B Abdulkadir A. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389 (10084): 2105-2116.
11. Myles PS Smith JA Forbes A Silbert B Jayarajah M Painter T Cooper DJ Marasco S McNeil J Bussières JS, ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-Artery surgery. N Engl J Med. 2017; 376 (2): 136-148.
12. Winter SF Santaguida C Wong J Fehlings MG. Systemic and topical use of tranexamic acid in spinal surgery: A systematic review. Global Spine J. 2016; 6 (3): 284-295.
13. Roberts I Shakur H Afolabi A Brohi K Coats T Dewan Y Gando S Guyatt G Hunt BJ Morales C. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377 (9771): 1096-1101,. 101.e1-101.e2.
14. Napolitano LM Cohen MJ Cotton BA Schreiber MA Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013; 74 (6): 1575-1586.
15. Novak DJ Bai Y Cooke RK Marques MB Fontaine MJ Gottschall JL Carey PM Scanlan RM Fiebig EW Shulman IA, PROPPR Study Group. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. Transfusion. 2015; 55 (6): 1331-1339.
16. Moore HB Moore EE Huebner BR Stettler GR Nunns GR Einersen PM Silliman CC Sauaia A. Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis. J Surg Res. 2017; 220: 438-443.
17. Roberts I Shakur H Afolabi A Brohi K Coats T Dewan Y Gando S Guyatt G Hunt BJ Morales C Perel P Prieto-Merino D Woolley T, CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377 (9771): 1096.e2-1101.e2.
18. Morrison JJ Dubose JJ Rasmussen TE Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012; 147 (2): 113-119.
19. Swendsen H Galante J Bateni G Scherer L Schermer C. Tranexamic acid use in trauma: effective but not with consequences. J Trauma Treat. 2013; 2 (179): 2167-1222.
20. Van Haren RM Valle EJ Thorson CM Jouria JM Busko AM Guarch GA Namias N Livingstone AS Proctor KG. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg. 2014; 76 (2): 443-449.
21. Valle EJ Allen CJ van Haren RM Jouria JM Li H Livingstone AS Namias N Schulman CI Proctor KG. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014; 76 (6): 1373-1378.
22. Howard JT Stockinger ZT Cap AP Bailey JA Gross KR. Military use of tranexamic acid in combat trauma: does it matter? J Trauma Acute Care Surg. 2017; 83 (4): 579-588.
23. Cole E Davenport R Willett K Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: A prospective cohort study. Ann Surg. 2015; 261 (2): 390-394.
24. Shiraishi A Kushimoto S Otomo Y Matsui H Hagiwara A Murata K, Japanese Observational Study for Coagulation and Thrombolysis in Early Trauma (J-OCTET) Investigators. Effectiveness of early administration of tranexamic acid in patients with severe trauma. Br J Surg. 2017; 104 (6): 710-717.
25. Harvin JA Peirce CA Mims MM Hudson JA Podbielski JM Wade CE Holcomb JB Cotton BA. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg. 2015; 78 (5): 905-911.
26. Prevention CfDCa. CDC Childhood Injury Report | Child Safety and Inj Prev| CDC Injury Center. CDC. 2017. Available at: https://www.cdc.gov/traumaticbrain-injury/get-the-facts.html. Accessed February 5, 2018.
27. Meizoso JP Dudaryk R Mulder MB Ray JJ Karcutskie CA Eidelson SA Namias N Schulman CI Proctor KG. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid. J Trauma Acute Care Surg. 2017; 84 (3): 426-432.
28. Holcomb JB Zarzabal LA Michalek JE Kozar RA Spinella PC Perkins JG Matijevic N Dong JF Pati S Wade CE, Trauma Outcomes Group. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma Acute Care Surg. 2011; 71 (2): S318-S328.